Literature DB >> 20373932

Two-year comparison of tension-free vaginal tape and transobturator tape for female urinary stress incontinence.

S George1, R Begum, A Thomas-Philip, L Thirumalakumar, O Sorinola.   

Abstract

Tension-free vaginal tape (TVT) and transobturator tape (TOT) are relatively new, minimally invasive procedures for the management of stress incontinence. All patients with urodynamic stress incontinence who underwent a TVT procedure from April 2003 to March 2005 (n = 76) were compared with all patients who had TOT from September 2004 to August 2006 (n = 73). The overall success rate for TVT was 97.4% and for TOT was 94.5%. Success was defined as no leakage, as reported by the patient at follow-up. Voiding difficulty in the TVT group was 9.2% for <1 week's duration and 2.6% for >1 week's duration, while in the TOT group, it was 4.1% and 1.4%, respectively. Bladder perforation was 1.3% in the TVT group but was 0 (none) in the TOT group. Both TOT and TVT have good success rates with minimal complications, although bladder perforation has a higher incidence rate in the TVT group.

Entities:  

Mesh:

Year:  2010        PMID: 20373932     DOI: 10.3109/01443610903551756

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

1.  TVT versus TOT, 2-year prospective randomized study.

Authors:  Bassem S Wadie; Ahmed S El-Hefnawy; Ahmed S Elhefnawy
Journal:  World J Urol       Date:  2012-09-26       Impact factor: 4.226

2.  Prospective and randomized clinical trial comparing transobturator versus retropubic sling in terms of efficacy and safety.

Authors:  Claudia Cristina Palos; Ana P Maturana; Frederico R Ghersel; Cesar E Fernandes; Emerson Oliveira
Journal:  Int Urogynecol J       Date:  2017-10-02       Impact factor: 2.894

Review 3.  Comparison between the retropubic and transobturator approaches in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications.

Authors:  Xincheng Sun; Qingsong Yang; Feng Sun; Qinglu Shi
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.